| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.007 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |